Target intelligence / Profile preview

WAP four-disulfide core domain protein 13 (WFDC13)

Target
WFDC13
Molecular classification
Other (Whey acidic protein four-disulfide core domain protein), Protease inhibitor
01

Overview

WAP four-disulfide core domain protein 13 (WFDC13) is a member of the WFDC (whey acidic protein four-disulfide core) domain family, characterized by a 40–50 amino acid domain that contains eight conserved cysteine residues forming four intramolecular disulfide bonds. The WFDC domain is primarily a structural protein motif with probable function as a protease inhibitor, especially antiprotease activity against serine proteases, although direct biochemical function for WFDC13 has not been fully established and remains putative. Most genes in the WFDC family are clustered on human chromosome 20q12-q13, with WFDC13 located in the telomeric cluster. WFDC proteins in general are implicated in host defense, immune regulation, and inhibition of various proteases, potentially relevant to tissue protection, inflammation, and antimicrobial activity, but no direct links for WFDC13 with specific diseases, biomarkers, or drug interactions are established in current public databases or literature. WFDC13 is referenced as a putative acid-stable proteinase inhibitor, but its precise biological function, disease association, and value as a therapeutic target are unconfirmed. Key contextual notes: - No evidence WFDC13 is currently a direct therapeutic target, receptor, or enzyme of drug interest. - No approved drugs or ligands, no direct safety concerns, and no established role in disease have been assigned in searched biomedical resources. - The structural domain is well described, but specific molecular and clinical relevance remains under-characterized in the literature.

Other names
C20orf138WAP13dJ601O1.3protein WFDC13protease inhibitor WAP13
02

Biological functions

Protease inhibitor (putative serine-type endopeptidase inhibitor activity)Possible role in host defense

Beyond the preview

Go deeper on WAP four-disulfide core domain protein 13 (WFDC13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WAP four-disulfide core domain protein 13 (WFDC13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call